Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Sourij, C; Aziz, F; Kojzar, H; Obermayer, AM; Sternad, C; Müller, A; Tripolt, NJ; Pferschy, PN; Aberer, F; Schlenke, P; Kleinhappl, B; Stradner, M; Sareban, N; Moritz, M; Dominguez-Villar, M; Oliver, N; Steinmetz, I; Sourij, H.
Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC-DM cohort study.
Diabetes Obes Metab. 2023; 25(1): 314-318. Doi: 10.1111/dom.14855 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Sourij Caren
Sourij Harald
Co-Autor*innen der Med Uni Graz
Aberer Felix
Aziz Faisal
Kleinhappl Barbara
Kojzar Harald
Moritz Martina
Müller Alexander
Obermayer Anna Maria Antonia
Pferschy Peter
Sareban Nazanin
Schlenke Peter
Steinmetz Ivo
Sternad Christoph Peter
Stradner Martin Helmut
Tripolt Norbert
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Find related publications in this database (using NLM MeSH Indexing)
Humans - administration & dosage
SARS-CoV-2 - administration & dosage
Diabetes Mellitus, Type 2 - administration & dosage
Cohort Studies - administration & dosage
Prospective Studies - administration & dosage
COVID-19 - prevention & control

Find related publications in this database (Keywords)
COVID-19
type 1 diabetes
type 2 diabetes
vaccination
© Med Uni Graz Impressum